Category Archives: Corporate

Top Stories for Week of March 30, 2020

Trump signs massive $2 trillion coronavirus stimulus bill. President Trump on Friday signed into law the largest economic stimulus package in modern American history, backing a $2-trillion measure designed to respond… Read more »

Top Stories for Week of March 2, 2020

As the situation worsens, Gilead begins two, late-stage studies to test drug for coronavirus. The coronavirus, or COVID-19, has infected more than 80,000 people in about three dozen countries since… Read more »

Medical Stock Spotlight – market’s stampede into stocks that could, even remotely, benefit from the coronavirus outbreak

Thinly traded nano cap Cleveland BioLabs Inc. (Nasdaq:CBLI) led advancing issues, skyrocketing 220% over the week to $4.23 as yet another company is caught up in the market’s stampede into… Read more »

Health-sector IPO action picks up where 2019 left off with new SEC filings signaling high hopes for cash still parked on the sidelines.

Despite clashes over trade sanctions pending resolution with China and threats of war with Iran escalating to nerve-wracking heights, confidence in the US market for health-sector initial public offerings apparently… Read more »

Biotech IPO scene shifts into pre-holiday slow gear, but several former IPOs are soaring with analysts saying Buy, Buy, Buy!

IPO Sector: US tech IPOs have mostly vanished in the fourth quarter following disappointments from multiple fast-growing, unprofitable unicorns. Healthcare (55% of 4Q IPOs) and Chinese issuers (24%) have hogged… Read more »

Healthcare stocks forge ahead despite trade-wars jitters; but that makes sense if you think about it.

Currently considered a “hedge” against the US-China trade clashes, which don’t bear directly on the provision of healthcare here in the US, here are the three top winners and a… Read more »

US stock market has a subdued Thanksgiving week, but a slew of healthcare companies rocketed higher.

Here’s the blistering action on the Nasdaq from last week, with four of the top gainers and one of the sorely downtrodden: ChemoCentryx Inc. (Nasdaq:CCXI) led advancing issues, skyrocketing 282%… Read more »

More Chinese medical companies choosing New York over Shanghai, Hong Kong for IPOs; but not always.

Three companies priced in New York last week–two biotechs and Chinese online real estate marketplace Shenzhen Fangdd Network Technology Co Ltd. (Nasdaq:DUO). The China-USA, free-floating trade anxieties aren’t dissuading the… Read more »

Health-sector IPO market cools off for Veterans Day breather; but pre-Thanksgiving deals ready to rock.

The IPO market for the health sector had a slow week for Veteran’s Day with just three small deals priced, registered and withdrawn. Five more industry-wide deals  are getting out… Read more »